Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG.F(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS.MI(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for TBPH

Stock NameTheravance Biopharma Inc
TickerTBPH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINKYG8807B1068
LEI5493007VTSXP4Z6MIW52

Show aggregate TBPH holdings

News associated with TBPH

Theravance Biopharma, Inc. (NASDAQ:TBPH) Short Interest Up 25.3% in August
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totaling 4,460,000 shares, an increase of 25.3% from the August 15th total of 3,560,000 shares. Based on an average trading volume of 333,700 shares, the short-interest ratio […] - 2025-09-19 05:28:56
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Average Recommendation of “Strong Buy” by Analysts
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) has been given an average recommendation of “Strong Buy” by the five brokerages that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company. The average 12-month target price […] - 2025-09-17 03:58:46
Theravance Biopharma (NASDAQ:TBPH) Hits New 1-Year High Following Strong Earnings
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $11.88 and last traded at $11.89, with a volume of 195285 shares. The stock had previously closed at $11.40. The biopharmaceutical company […] - 2025-08-13 03:58:43
Bank of New York Mellon Corp Raises Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Bank of New York Mellon Corp grew its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 1.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 117,499 shares of the biopharmaceutical company’s stock after buying an additional 1,720 shares during the […] - 2025-08-01 05:26:59
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by GSA Capital Partners LLP
GSA Capital Partners LLP raised its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 11.9% during the 1st quarter, HoldingsChannel.com reports. The firm owned 182,350 shares of the biopharmaceutical company’s stock after acquiring an additional 19,363 shares during the period. GSA Capital Partners LLP’s holdings in Theravance Biopharma were worth $1,628,000 at the […] - 2025-07-30 05:44:43
Alps Advisors Inc. Sells 3,680 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Alps Advisors Inc. decreased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 9.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,079 shares of the biopharmaceutical company’s stock after selling 3,680 shares during the period. […] - 2025-07-18 05:49:01
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-07-17 05:40:54
Jones Trading Initiates Coverage on Theravance Biopharma (NASDAQ:TBPH)
Jones Trading initiated coverage on shares of Theravance Biopharma (NASDAQ:TBPH – Get Free Report) in a note issued to investors on Tuesday,Benzinga reports. The firm set a “buy” rating and a $24.00 price target on the biopharmaceutical company’s stock. Jones Trading’s target price suggests a potential upside of 125.99% from the stock’s current price. TBPH […] - 2025-06-19 03:18:55
Wellington Management Group LLP Acquires 7,162 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Wellington Management Group LLP raised its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 198,491 shares of the biopharmaceutical company’s stock after buying an additional 7,162 shares during […] - 2025-06-06 07:12:49
Public Employees Retirement System of Ohio Buys New Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Public Employees Retirement System of Ohio bought a new stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 37,461 shares of the biopharmaceutical company’s stock, valued at approximately $353,000. Other hedge funds […] - 2025-06-05 07:14:52
Squarepoint Ops LLC Has $444,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Squarepoint Ops LLC cut its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 52.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 47,168 shares of the biopharmaceutical company’s stock after selling 51,783 shares during the period. Squarepoint Ops LLC’s holdings in Theravance Biopharma were worth $444,000 as of […] - 2025-06-05 06:16:56
ProShare Advisors LLC Acquires New Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
ProShare Advisors LLC acquired a new stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 12,672 shares of the biopharmaceutical company’s stock, valued at approximately $119,000. A number of other hedge funds have also added to or reduced their stakes in TBPH. Newtyn Management LLC […] - 2025-06-03 06:26:49
Ameriprise Financial Inc. Lowers Stock Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Ameriprise Financial Inc. reduced its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 9.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,807 shares of the biopharmaceutical company’s stock after selling 10,825 shares during the period. Ameriprise Financial Inc.’s holdings in […] - 2025-06-02 05:19:00
Man Group plc Sells 14,851 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Man Group plc reduced its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 59.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,328 shares of the biopharmaceutical company’s stock after selling 14,851 shares during the quarter. Man […] - 2025-05-29 06:36:58
Dimensional Fund Advisors LP Has $5.21 Million Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Dimensional Fund Advisors LP raised its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 553,713 shares of the biopharmaceutical company’s stock after buying an additional 95,304 shares during the […] - 2025-05-13 07:14:52
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by Tower Research Capital LLC TRC
Tower Research Capital LLC TRC grew its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 142.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,670 shares of the biopharmaceutical company’s stock after purchasing an additional 7,452 shares during the period. Tower Research Capital […] - 2025-05-09 06:22:54
Barclays PLC Raises Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Barclays PLC increased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 14.0% in the 4th quarter, HoldingsChannel reports. The firm owned 74,790 shares of the biopharmaceutical company’s stock after purchasing an additional 9,210 shares during the period. Barclays PLC’s holdings in Theravance Biopharma were worth $704,000 as of its most […] - 2025-05-08 05:36:46
XTX Topco Ltd Reduces Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
XTX Topco Ltd lessened its holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,356 shares of the biopharmaceutical company’s stock after selling 4,083 shares during the period. XTX Topco Ltd’s holdings in Theravance […] - 2025-04-29 06:24:51
10,937 Shares in Theravance Biopharma, Inc. (NASDAQ:TBPH) Bought by Teacher Retirement System of Texas
Teacher Retirement System of Texas acquired a new position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 10,937 shares of the biopharmaceutical company’s stock, valued at approximately $103,000. Other institutional investors have […] - 2025-04-03 05:16:48
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of “Hold” by Analysts
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have been assigned a consensus rating of “Hold” from the five brokerages that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price […] - 2025-03-27 04:55:16
Bank of New York Mellon Corp Sells 5,282 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Bank of New York Mellon Corp trimmed its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 115,779 shares of the biopharmaceutical company’s stock after selling 5,282 shares during the quarter. Bank of New York Mellon Corp’s holdings in Theravance Biopharma were worth $1,089,000 […] - 2025-03-25 05:14:50
Theravance Biopharma (NASDAQ:TBPH) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $15.00 price objective on the biopharmaceutical company’s stock. Theravance Biopharma Trading Up 1.2 % TBPH opened at $8.97 on Tuesday. Theravance Biopharma has a 12-month low of […] - 2025-02-26 06:49:00

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc TBPH holdings

DateNumber of TBPH Shares HeldBase Market Value of TBPH SharesLocal Market Value of TBPH SharesChange in TBPH Shares HeldChange in TBPH Base ValueCurrent Price per TBPH Share HeldPrevious Price per TBPH Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TBPH by Blackrock for IE00B3VWM098

Show aggregate share trades of TBPH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-09-22SELL-11217.08017.030 17.035USD -1,908 13.74 Loss of -369 on sale
2026-09-18SELL-1,00817.05017.020 17.023USD -17,159 13.71 Loss of -3,340 on sale
2026-09-17SELL-1,00817.04017.020 17.022USD -17,158 13.69 Loss of -3,356 on sale
2026-09-14SELL-11217.04517.010 17.014USD -1,906 13.64 Loss of -378 on sale
2026-09-08SELL-33617.10017.060 17.064USD -5,734 13.59 Loss of -1,167 on sale
2026-09-04SELL-11217.25517.070 17.088USD -1,914 13.55 Loss of -396 on sale
2026-08-21SELL-22417.02016.960 16.966USD -3,800 13.38 Loss of -803 on sale
2026-08-18SELL-33616.96016.930 16.933USD -5,689 13.32 Loss of -1,213 on sale
2026-08-17SELL-22416.97016.920 16.925USD -3,791 13.30 Loss of -811 on sale
2026-08-14SELL-22416.99016.910 16.918USD -3,790 13.28 Loss of -814 on sale
2026-08-05BUY56016.91016.860 16.865USD 9,444 13.11
2026-08-03BUY78416.88016.860 16.862USD 13,220 13.09
2026-07-28SELL-22416.92016.880 16.884USD -3,782 13.00 Loss of -870 on sale
2026-07-21BUY11216.90016.835 16.841USD 1,886 12.93
2026-07-16BUY11216.99516.930 16.937USD 1,897 12.86
2026-07-10SELL-22417.02016.905 16.917USD -3,789 12.75 Loss of -933 on sale
2026-07-06BUY11217.05016.940 16.951USD 1,899 12.67
2026-07-01BUY56017.06516.960 16.970USD 9,503 12.61
2026-06-30BUY11217.14516.940 16.961USD 1,900 12.58
2026-06-26BUY67217.72017.290 17.333USD 11,648 12.52
2026-06-22BUY22416.93016.410 16.462USD 3,687 12.42
2026-06-17BUY44816.81016.545 16.572USD 7,424 12.36
2026-06-16BUY11216.71016.280 16.323USD 1,828 12.33
2026-06-15BUY2,24016.61016.210 16.250USD 36,400 12.31
2026-06-12BUY22416.67016.420 16.445USD 3,684 12.27
2026-06-11BUY2,77516.57516.355 16.377USD 45,446 12.24
2026-06-10BUY44416.62016.300 16.332USD 7,251 12.21
2026-06-02BUY22215.83015.520 15.551USD 3,452 12.03
2026-05-29BUY13,76216.25016.003 16.028USD 220,573 11.97
2026-05-22SELL-19516.43016.180 16.205USD -3,160 11.80 Loss of -859 on sale
2026-05-20SELL-26016.58016.280 16.310USD -4,241 11.72 Loss of -1,192 on sale
2026-05-19SELL-13016.33216.010 16.042USD -2,085 11.69 Loss of -566 on sale
2026-05-13SELL-32516.76016.310 16.355USD -5,315 11.53 Loss of -1,569 on sale
2026-05-12SELL-32516.67016.401 16.428USD -5,339 11.48 Loss of -1,607 on sale
2026-05-11BUY6516.97516.420 16.476USD 1,071 11.44
2026-05-08BUY6517.07016.605 16.651USD 1,082 11.39
2026-05-07BUY13017.05516.620 16.664USD 2,166 11.34
2026-05-05SELL-39017.17016.650 16.702USD -6,514 11.25 Loss of -2,128 on sale
2026-04-30BUY32516.82016.530 16.559USD 5,382 11.14
2026-04-20BUY6517.14016.600 16.654USD 1,083 10.83
2026-04-17BUY13017.24016.740 16.790USD 2,183 10.76
2026-04-15SELL-26016.80516.400 16.440USD -4,275 10.71 Loss of -1,491 on sale
2026-04-13SELL-19516.56516.215 16.250USD -3,169 10.59 Loss of -1,104 on sale
2026-04-08SELL-39016.82016.510 16.541USD -6,451 10.47 Loss of -2,368 on sale
2026-04-07SELL-58516.58016.030 16.085USD -9,410 10.41 Loss of -3,322 on sale
2026-03-30SELL-6515.59014.710 14.798USD -962 10.04 Loss of -309 on sale
2026-03-27SELL-65 15.080* 9.99 Profit of 649 on sale
2026-03-26SELL-65 15.190* 9.93 Profit of 645 on sale
2026-03-23BUY8,704 14.750* 9.75
2026-03-16SELL-836 13.930* 9.65 Profit of 8,070 on sale
2026-03-13SELL-114 13.780* 9.60 Profit of 1,095 on sale
2026-03-11BUY190 13.810* 9.50
2026-03-05BUY114 13.580* 9.28
2026-03-04BUY76 13.665* 9.22
2025-03-04SELL-749.1009.220 9.208USD -681 9.22 Profit of 1 on sale
2025-02-28SELL-5,4629.3509.520 9.503USD -51,905 9.22 Loss of -1,554 on sale
2025-02-26SELL-159.0809.110 9.107USD -137 9.22 Profit of 2 on sale
2025-02-25SELL-458.9709.140 9.123USD -411 9.22 Profit of 5 on sale
2025-02-13BUY159.4809.595 9.584USD 144 9.18
2025-02-12BUY159.3609.400 9.396USD 141 9.18
2025-02-11BUY459.0409.485 9.440USD 425 9.18
2025-02-06BUY1359.5109.760 9.735USD 1,314 9.17
2025-01-27BUY159.67010.460 10.381USD 156 9.10
2025-01-22SELL-309.3609.450 9.441USD -283 9.06 Loss of -12 on sale
2025-01-17SELL-158.5808.590 8.589USD -129 9.08 Profit of 7 on sale
2025-01-16BUY158.4408.620 8.602USD 129 9.09
2025-01-14BUY458.5308.700 8.683USD 391 9.12
2025-01-13BUY308.5708.760 8.741USD 262 9.13
2025-01-08BUY909.0509.380 9.347USD 841 9.15
2024-12-30BUY759.4709.720 9.695USD 727 9.13
2024-12-06BUY609.88010.005 9.993USD 600 9.05
2024-12-05BUY159.8409.880 9.876USD 148 9.02
2024-12-04BUY759.5909.975 9.937USD 745 9.00
2024-11-29BUY759.2509.490 9.466USD 710 8.94
2024-11-27BUY609.4209.560 9.546USD 573 8.90
2024-11-26BUY159.2409.500 9.474USD 142 8.88
2024-11-21BUY759.6109.970 9.934USD 745 8.78
2024-11-20BUY459.97010.100 10.087USD 454 8.72
2024-11-18BUY1809.4909.675 9.657USD 1,738 8.59
2024-11-12BUY1208.9109.085 9.068USD 1,088 8.57
2024-11-08BUY758.9408.950 8.949USD 671 8.55
2024-11-07BUY2258.7508.810 8.804USD 1,981 8.53
2024-11-06BUY308.7108.730 8.728USD 262 8.51
2024-10-31BUY158.2408.575 8.541USD 128 8.65
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TBPH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1946,143069,38466.5%
2025-09-1880,190117112,01271.6%
2025-09-1775,5940114,22166.2%
2025-09-1670,7650139,69050.7%
2025-09-15105,409400172,83961.0%
2025-09-12136,735151333,53041.0%
2025-09-1174,0190120,26961.5%
2025-09-1073,4840124,15159.2%
2025-09-0969,711097,56971.4%
2025-09-0871,9360104,44268.9%
2025-09-05144,1790270,63553.3%
2025-09-04113,312100178,97763.3%
2025-09-03147,2450195,02375.5%
2025-09-02210,6440362,99158.0%
2025-08-29143,618600181,27579.2%
2025-08-2891,8510163,38356.2%
2025-08-2738,465086,67344.4%
2025-08-2655,7550101,81254.8%
2025-08-25176,328101,189252,59469.8%
2025-08-22126,2660309,77340.8%
2025-08-21108,9940183,42759.4%
2025-08-2064,55616,67288,17873.2%
2025-08-1962,998230140,05445.0%
2025-08-18128,4990383,24433.5%
2025-08-1575,5620251,50130.0%
2025-08-14108,2130315,70934.3%
2025-08-13102,3020184,57555.4%
2025-08-1275,6780174,75943.3%
2025-08-1140,324088,88645.4%
2025-08-0837,6510439,9058.6%
2025-08-0716,105037,94642.4%
2025-08-0628,678042,92366.8%
2025-08-0538,161059,31964.3%
2025-08-0435,7174461,07458.5%
2025-08-0130,9431,10042,16073.4%
2025-07-3131,614042,70474.0%
2025-07-3033,096053,70461.6%
2025-07-2917,238034,55549.9%
2025-07-2815,392034,14945.1%
2025-07-2531,283043,72071.6%
2025-07-2410,550026,05840.5%
2025-07-2322,148031,10071.2%
2025-07-2220,402031,93663.9%
2025-07-2118,084037,42748.3%
2025-07-1821,942934,99262.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy